Most patients experience side effects primarily during the first 4 to 8 weeks and find they diminish as the dose stabilizes
Zhu B, Li L, Wei R, Liang P, Gao X
When you inject the medication into the subcutaneous fat (the layer of fat just under the skin), it begins to enter the bloodstream gradually
Cardiovascular Risk Profile: Even without significant obesity, patients with established heart disease, prior stroke, or multiple cardiac risk factors benefit from the cardiovascular protective effects beyond weight loss alone
Dispose immediately in sharps container
Holderbaum 2018 systematic review Chakravartty 2019 RCT VLCD safety (short-term, supervised): Classic and consensus statements on efficacy/safety when medically monitored